Search

Your search keyword '"Musto, Pellegrino"' showing total 70 results

Search Constraints

Start Over You searched for: Author "Musto, Pellegrino" Remove constraint Author: "Musto, Pellegrino" Database Journals@OVID Remove constraint Database: Journals@OVID
70 results on '"Musto, Pellegrino"'

Search Results

3. ITACA: A new validated international erythropoietic stimulating agent‐response score that further refines the predictive power of previous scoring systems

5. Lenalidomide and low‐dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials

6. Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia

9. Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study

10. Supplement to: Autologous Transplantation and Maintenance Therapy in Multiple Myeloma

13. Autologous Transplantation and Maintenance Therapy in Multiple Myeloma

15. Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study

16. MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients

19. Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study

21. Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

23. Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles

25. Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas: Phase 2 study of the Italian Lymphoma Foundation

27. A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia

31. An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients

32. An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients

34. BRAF Mutations in Hairy-Cell Leukemia

35. Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study

38. Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA

39. Considerations in the treatment of multiple myeloma: a consensus statement from Italian experts

Catalog

Books, media, physical & digital resources